Established in 2019 as an Italian startup, FLIM LABS has swiftly risen as a pioneer in the dynamic realm of fluorescence lifetime analysis technology. Founded by Alessandro Rossetta, Ph.D., in Bioengineering and now led by him as CEO, the company traces its origins back to its inception with the support of ‘PRE-SEED’ funds from Regione Lazio. Since then, FLIM LABS has seen continuous growth, earning accolades from esteemed institutions like Regione Emilia Romagna and the Photon Hub Europe technology accelerator programs. Since January 2024, FLIM LABS has remained at the forefront of fluorescence lifetime analysis technology, leading the LaserBlood EIC Pathfinder consortium in developing a groundbreaking method for early pancreatic cancer diagnosis via liquid biopsy.

At the core of FLIM LABS’ mission is a dedication to providing reliable, portable, user-friendly, and affordable fluorescence lifetime analysis tools. These tools are engineered to seamlessly acquire and process fluorescence lifetime data in real time, embodying a commitment to both technological innovation and practicality. FLIM LABS’ instruments are designed to be plug-and-play, remarkably user-friendly, and easily upgradable.

Devoted to advancing fluorescence lifetime technology, FLIM LABS distinguishes itself as one of the few companies focused on developing specialized technical components tailored for fluorescence lifetime experiments. By championing accessibility and simplicity, FLIM LABS is breaking down barriers, making fluorescence lifetime-based technology accessible to a broader community of scientists and researchers, poised to explore new horizons.


Alessandro Rossetta is the driving force behind FLIM LABS’ commitment to push boundaries and unlock new horizons. Serving as both CEO of the company and Project Coordinator of the LaserBlood EIC Pathfinder consortium, Alessandro brings an MSc in Biomedical Engineering earned from the University of California, Irvine in 2016 where he worked at the Laboratory for Fluorescence Dynamics. Alessandro personally designs and develops FLIMLABS’ instrumentation for fluorescence lifetime analysis.

Alessandro’s journey further evolved during his Ph.D. in Bioengineering at the Istituto Italiano di Tecnologia in Genoa. During this time, he focused on the development of an open-source time tagging platform, resulting in a publication in Nature Communications and a release of his PhD work on GitHub.

After completing his Ph.D., when he began working full-time at FLIM LABS, he spearheaded the development of an innovative suite of tools for detecting and analyzing fluorescence lifetime data. In 2023, this groundbreaking generation of fluorescence lifetime analysis tools emerged, poised to revolutionize scientific and industrial landscapes.

Since its establishment in 2019, FLIM LABS has rapidly evolved as a dynamic deep-tech startup, driving advancements in fluorescence lifetime analysis technology and applications. The company’s extensive academic collaborations and consistent recognition underscore its pivotal role in shaping the future of the fluorescence lifetime field.